Science AI Journal
Medicine · Research topic

Open research questions in Trypanosoma species research and implications

81 unresolved questions extracted from the limitations and future-work sections of 163 Trypanosoma species research and implications papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • The difficulty in purifying endogenous SL trans-splicing intermediates from Leishmania tarentolae. The challenge of determining the structural basis of step II SL trans-splicing. The need to develop a mechanistic framework for SL trans-splicing that accounts for lineage-specific adaptations.

    Structural basis of step II spliced leader RNA trans-splicing in trypanosomatid parasites · 2026 · DOI

  • The lack of understanding of the structural and mechanistic basis of SL trans-splicing. The incomplete definition of the composition of spliceosomal subunits in trypanosomatids. The need for a mechanistic framework for SL trans-splicing.

    Structural basis of step II spliced leader RNA trans-splicing in trypanosomatid parasites · 2026 · DOI

  • Underdiagnosed and undertreated individuals in non-endemic areas, - Heterogeneity of healthcare systems, - Challenges of collecting longitudinal data in dogs, - Limited experience of veterinarians in recognizing signs of Chagas disease in non-endemic areas

    Chagas Disease: A Silent Threat for Dogs and Humans · 2024 · DOI

  • Development of prophylactic and therapeutic vaccines, - Development of diagnostic tools to identify T. cruzi infection in dogs and other domestic animals, - Study of the epidemiological relevance of the dog population in different countries, - Investigation of the transmission dynamics of T. cruzi in non-endemic areas

    Chagas Disease: A Silent Threat for Dogs and Humans · 2024 · DOI

  • A comprehensive in silico evaluation integrating molecular interaction analysis, pharmacokinetic profiling, toxicity prediction, and molecular dynamics simulations has not yet been reported.

    Integrating Molecular Docking, Dynamics, and AI-Based ADMET Prediction to Decipher the Toxicity Profile of Isometamidium Chloride Against Animal Trypanosomiasis · 2026 · DOI

  • Despite this, their ER and Golgi luminal proteomes remain incompletely characterized.

    A luminal proteome of the endoplasmic reticulum and Golgi apparatus reveals a novel modulator of ER stress tolerance in African trypanosomes · 2026 · DOI

  • The associations between parasite diversity and ecology are not absolute. There is a need for a better understanding of the genetic basis of drug resistance in T. cruzi.

    Trypanosoma cruzi Genetic Diversity Challenges Eco-Epidemiological Associations and Requires Integrated Biological-Social Approaches for Chagas Disease Management · 2026 · DOI

  • The presence of multiple vector triatomine insects and Trypanosoma cruzi infection in animals in the United States poses a challenge for disease control. The lack of evidence for endemic Chagas disease in the United States is a challenge for public health policy.

    Evidence Lacking for Endemic Chagas Disease in the United States · 2026 · DOI

  • Future studies to evaluate rHEV-specific serologic response could be useful. The paper suggests the need for continued surveillance and monitoring of Chagas disease in the United States.

    Evidence Lacking for Endemic Chagas Disease in the United States · 2026 · DOI

  • The high cost, ethical considerations, and logistic challenges associated with non-human primate research limit their widespread use. The use of laboratory animal models has limitations, including the need for large numbers of animals and the potential for variability in results.

    A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate · 2026 · DOI

  • Future research should focus on developing more efficient and effective methods for drug development, including the use of in silico tools and alternative animal models. The development of new technologies and approaches is needed to address the challenges associated with kinetoplastid diseases.

    A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate · 2026 · DOI

  • The disease can progress to chronic Chagas cardiomyopathy if not timely diagnosed and treated. There is a lack of effective diagnostic tests for Chagas disease in non-endemic areas. The disease is often asymptomatic, making diagnosis challenging.

    Towards new care strategies in a suburban healthcare center in La Matanza, Argentina: performance evaluation of rapid diagnostic tests for Chagas disease in a non-endemic area · 2026 · DOI

  • The study was conducted in a single non-endemic area. The sample size was limited to 103 subjects. The study did not evaluate the long-term performance of the rapid diagnostic tests.

    Towards new care strategies in a suburban healthcare center in La Matanza, Argentina: performance evaluation of rapid diagnostic tests for Chagas disease in a non-endemic area · 2026 · DOI

  • Evaluation of the Multi-Cruzi platform in a clinical setting. Identification of new antigens and development of new tests. Assessment of the platform's performance in different patient populations.

    Epitope mapping and conservation of antigens from the Multi-Cruzi immunoassay platform · 2026 · DOI

  • The lack of a gold standard for Chagas disease diagnosis. The limited performance of current diagnostic tests. The need for new antigens and tests with enhanced performance.

    Epitope mapping and conservation of antigens from the Multi-Cruzi immunoassay platform · 2026 · DOI

  • optimization efforts to generate additional guanidine-containing scaffolds - further investigation of the structure-activity relationship trends - exploration of guanidine-based antitubercular agents

    Guanidines: Privileged Scaffolds Against Neglected Tropical Diseases: A Review · 2026 · DOI

  • The study aims to assess the trend of CD testing and diagnosis across different datasets and cardiac subgroups. There is a need to examine the annual prevalences of CD testing and diagnosis overall and within non-mutually exclusive cardiac subgroups.

    Chagas Cardiomyopathy in the United States: Testing and Diagnosis Across Real-World Datasets · 2026 · DOI

  • brucei infection, whether parasites can directly infiltrate the female reproductive tract (FRT), and how infection may reshape the FRT immune landscape remains poorly understood.

    Trypanosoma brucei infection remodels the uterine immune environment and drives neuroendocrine dysfunction · 2026 · DOI

  • The absence of an effective vaccine for trypanosomiasis due to the parasite’s immune-evasion strategy of Antigenic Variation. The need for a new approach that targets conserved functional vulnerabilities and incorporates population-level transmission dynamics.

    Beyond antigenic variation: A review of innovative immuno-epidemiologic approaches to trypanosomiasis vaccine design · 2026 · DOI

  • The absence of canonical promoter-based transcriptional regulation in Leishmania. The lack of identifiable canonical promoters in Leishmania. The complexity of post-transcriptional control in Leishmania.

    Initiation codon context governs translation-coupled mRNA decay and coordinated expression in the human parasite Leishmania · 2026 · DOI

  • Limited availability of diagnostic kits for surra. Limited understanding of the epidemiology of T. evansi infection in cattle in Kyrgyzstan. Difficulty in detecting T. evansi infection due to its asymptomatic nature in cattle.

    Trypanosoma evansi Infection in Cattle from the Northern Mountainous Regions of Kyrgyzstan · 2026 · DOI

  • The test has limited species specificity, with potential cross-reactions with other Trypanozoon species and T. vivax. The test can produce nonspecific agglutination. The study did not use a combination of diagnostic methods.

    Trypanosoma evansi Infection in Cattle from the Northern Mountainous Regions of Kyrgyzstan · 2026 · DOI

  • The study only used in silico methods, no experimental validation was performed. The molecular dynamics simulations were limited to 100 ns. The study only considered superoxide dismutases from trypanosomatids and humans.

    Identification and characterization of putative allosteric sites on superoxide dismutases for use as species-specific drug targets to parasitic trypanosomatids · 2026 · DOI

  • Experimental validation of the identified allosteric sites. Application of the workflow to other proteins and diseases. Development of new treatments targeting the identified allosteric sites.

    Identification and characterization of putative allosteric sites on superoxide dismutases for use as species-specific drug targets to parasitic trypanosomatids · 2026 · DOI

  • investigating how the putative regulatory switch operates, - mechanistic analyses of the regulatory networks, - experimental strategies for downstream analyses

    Five-layer systems analysis of Leishmania stage differentiation reveals an essential role for protein degradation in parasite development · 2026 · DOI

Most-cited papers in Trypanosoma species research and implications

Most recent work

Find a gap in your own Trypanosoma species research and implications sub-topic

This page shows what the Trypanosoma species research and implications literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,044 open questions
Substance Abuse Treatment and Outcomes
1,964 open questions
Smoking Behavior and Cessation
990 open questions
Dementia and Cognitive Impairment Research
974 open questions
Innovations in Medical Education
960 open questions
Physical Activity and Health
923 open questions
Attention Deficit Hyperactivity Disorder
839 open questions
Schizophrenia research and treatment
709 open questions
81 open questions have been extracted from the limitations and future-work passages of 163 Trypanosoma species research and implications papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.